NASDAQ · Healthcare · Biotechnology
Ardelyx, Inc.
ARDX
Ardelyx, Inc. CEO Michael G. Raab · Market cap $1.6B.
$6.43
-0.17 · -2.65%
52w hi $8.4052w lo $3.21
Off 52w high 29.2%
62
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $17.00
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Feb 20 | David M Mott | Buy | 333,333 | $5.84 | +$1.95M | 62 | |
| Jun 16 | David M Mott | Buy | 200,000 | $3.63 | +$726K | 56 | |
| Jun 09 | David M Mott | Buy | 200,000 | $3.69 | +$737K | 56 | |
| May 15 | David M Mott | Buy | 100,000 | $3.29 | +$329K | 36 | |
| May 02 | David M Mott | Buy | 381,377 | $4.22 | +$1.61M | 62 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay